Marks Breyanzi’s fourth indication in Europe, adding to existing approvals for several aggressive B-cell lymphomas.

BioMed X has launched a new collaborative research project with AbbVie, hosted at the BioMed X Institute in New Haven, ...

The European Commission has approved Sanofi and Regeneron’s Dupixent for the treatment of moderate-to-severe chronic spontaneous urticaria.

AstraZeneca is investing $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes an ...

The Future of Oral Solids explores how innovation, advanced manufacturing, and integrated CDMO partnerships are reshaping the ...

Novartis is expanding its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end ...

Alex Mitchell, Vice President, Operations, Sentry BioPharma Services, discusses the growing use of FTZs by pharmaceutical ...

AGC Biologics has entered a new manufacturing agreement with AAVantgarde, marking AGC Biologics’ latest advancement in the ...

A conversation with Upperton’s Director of Pharmaceutical Sciences, Laura Mason about the upcoming trends she sees emerging ...

Agenus Inc., an immune-oncology company, has appointed José Iglesias, M.D. as Chief Medical Affairs Officer.

David Basile of Hovione discusses expanded spray drying capacity in East Windsor and the benefits of integrated development, ...

Sonoma Biotherapeutics Inc. has appointed Stephen Dilly, former President and CEO of Codexis Inc., and current Chair of the ...